Search Cancer Clinical Trials
Home > Cancer (Oncology) > Research and Clinical Trials > Clinical Trials > Search Cancer Clinical Trials

Research and Clinical Trials

Search Cancer Clinical Trials

Clinical Trials

New Search
Title Principal Investigator Post Date
A Phase 2 Study Comparing Chemotherapy in Combination with OGX-427 or Placebo in Patients With Bladder Cancer Sanjay Goel, MD   
A Phase 2 Study Of Dacomitinib In Advanced Non-Small Cell Lung Cancer (Post-Chemotherapy Or Select First Line Patients) To Evaluate Prophylactic Intervention On Dermatologic And Gastrointestinal Adverse Events And Patient Reported Outcomes Bilal Piperdi, MD   
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi (BELLE-3) Eleni Andreopoulou, MD    
A pilot randomized trial comparing arm circumference and bioimpedence measurement for early detection and treatment of lymphedema in patients undergoing axillary lymph node dissection or sentinel node biopsy Lisa Wiechmann, MD   
A Registry of Sipuleucel-T A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer (PROCEED) Sanjay Goel, MD   
A single-arm, open-label, multi-center study of complete molecular response (CMR) in adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP) Olga Derman, MD   
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib. Bilal Piperdi, MD   
A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer Joseph Sparano, MD   
A Study of Tarceva Before Surgery in Non-Small Cell Lung Cancer Patients Who Have EGFR Positive Tumors. (EVENT) Bilal Piperdi, MD   
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3) Sanjay Goel, MD   
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia (ASPIRE) Amit Verma, MD   
A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma Stuart Packer, MD   
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors Sanjay Goel, MD   
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer Santiago Aparo, MD   
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer (AFFINITY) Sanjay Goel, MD   
Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors (MACS1938) Steven K. Libutti, MD   
Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer Christine Pellegrino, MD   06/10/2010 
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy Missak Haigentz, MD   
Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients Mark Einstein, MD   
Phase II Study of Lenalidomide and Eltrombopag in Patients with Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome Amit Verma, MD   
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Stefan Barta, MD   
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV) Jerome Graber, MD   
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Joseph Sparano, MD   
Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Fulvestrant (Faslodex) Plus Everolimus in Post-Menopausal Patients With Hormone-Receptor Positive Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy Della Makower, MD    
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (DEFLECT-1) Stefan Barta, MD   
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) Mark Einstein, MD    
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions Sanjay Goel, MD   
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting (SIMPLICITY) Stefan Barta, MD